BLCM might be putting in a bottom here at the VWAP from March low and the 50% retracement level of move off March low. Worth keeping on your radar.
Comment
⋅
VWAP from low did not hold. No plans for entry here.
Important to know that BLCM is a 24 mil mkt cap stock with an Immunotherapy/Oncology focus and they are working on solid tumors and Car-T therapy, which is pretty sexy stuff nowadays, keep an eye out for catalysts. I may initiate a small position before an upcoming data readout
Comment
⋅
Although it fell 20-30% below my initial proposed entry, BLCM actually looks quite attractive breaking above on high volume and now pulling back to the downtrend line